Aigen Investment Management, LP Heron Therapeutics, Inc. Transaction History

Aigen Investment Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$2.32 - $3.86 $31,282 - $52,048	13,484 New	13,484 $47,000
Q1 2022 May 05, 2022	SELL	$4.63 - $9.94 $91,757 - $196,990	-19,818 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$8.35 - $12.6 $165,480 - $249,706	19,818 New	19,818 $179,000
Q1 2020 May 08, 2020	SELL	$10.23 - $24.56 $383,717 - $921,221	-37,509 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$17.42 - $26.61 $653,406 - $998,114	37,509 New	37,509 $881,000

181

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $141M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.